HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefanie Ripka Selected Research

4- aminophenyl- 1,2- dihydro- 1- methyl- 2- propylcarbamoyl- 6,7- methylenedioxyphthalazine

8/2010Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefanie Ripka Research Topics

Disease

4Pancreatic Neoplasms (Pancreatic Cancer)
12/2013 - 08/2010
2Neoplasms (Cancer)
12/2013 - 08/2010

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2013 - 12/2010
1Phosphotransferases (Kinase)IBA
12/2013
1ErbB Receptors (EGF Receptor)IBA
12/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2013
1Pharmaceutical PreparationsIBA
12/2013
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
12/2013
1polypeptide 3 90kDa ribosomal protein S6 kinaseIBA
12/2013
1Transcription Factors (Transcription Factor)IBA
01/2013
1Biomarkers (Surrogate Marker)IBA
12/2010
1Glutamate Receptors (Glutamate Receptor)IBA
08/2010
1Glutamic Acid (Glutamate)FDA Link
08/2010
14- aminophenyl- 1,2- dihydro- 1- methyl- 2- propylcarbamoyl- 6,7- methylenedioxyphthalazineIBA
08/2010

Therapy/Procedure

2Therapeutics
12/2013 - 12/2010
1Drug Therapy (Chemotherapy)
12/2013